Jaripatka, Nagpur, Maharashtra
GST No. 27ABYFA5130A1ZL
Approx. Rs 1,900 / BottleGet Latest Price
Product Details:Manufacture By | Laurus Labs Limited |
Packaging Size | 120 |
Composition | LOPINAVIR 200MG + RITONAVIR 50MG |
Treatment | Second Line ARV |
Item Name | Prolavir LR |
Drug Name | LOPINAVIR 200MG + RITONAVIR 50MG |
Pack Type | Bottle |
Packing Type | Bottle |
Country of Origin | Made in India |
Approx. Rs 8,689 / BottleGet Latest Price
Product Details:Packaging Size | 60 Tablets |
Composition | Raltegravir 400mg (Zepdon and Isentress Generic) |
Treatment | Hiv |
Form | Tablet |
Shelf life | 24 MONTHS |
Product Name | Raltegravir 400mg |
Item Name | Raltegravir 400mg |
Manufacture By | Mcneil & Argus Pharmaceuticals Limited |
Country of Origin | Made in India |
Approx. Rs 2,000 / PackGet Latest Price
Product Details:Treatment | hiv drugs |
Composition | tenofovir |
Packaging Size | 1*30 |
Shelf life | 24 MONTHS |
Form | Tablet |
Country of Origin | Made in India |
Approx. Rs 3,800 / BottleGet Latest Price
Product Details:Packaging Size | 30 tablets |
Composition | Tenofovir (300 mg) + Emtricitabine (200 mg) + Efavirenz (600 mg) |
Treatment | HIV treatment |
Form | Tablet |
Shelf life | 24 MONTHS |
Country of Origin | Made in India |
Trustiva Tablet 30's belongs to the group of medicines called antiretroviral therapy. Trustiva Tablet 30's contains Emtricitabine, Tenofovir Disoproxil Fumarate and Efavirenz. Trustiva Tablet 30's works by inhibiting the reverse transcriptase enzyme production, which is necessary to multiply the viruses. This effect helps to inhibit viral replication and treats HIV infection.
Directions for UseTrustiva Tablet 30's should be swallowed as a whole with a glass of water. Do not crush, chew, or break it. It should be taken on an empty stomach 1 hour before or 2 hours after a meal, preferably at bedtime. Your doctor will prescribe the dose and duration based on your health condition.Approx. Rs 800 / BottleGet Latest Price
Product Details:Packaging Size | 60 Tablets |
Composition | Lopinavir & Ritonavir |
Treatment | HIV |
Form | Tablet |
Country of Origin | Made in India |
Approx. Rs 18,000 / BottleGet Latest Price
Product Details:Minimum Order Quantity | 10 Bottle |
Packaging Type | Bottle |
Composition | Sofosbuvir 400 mg + Daclatasvir 60 mg Tablets |
Packaging Size | 28 tablets |
Brand | Sofokast Plus |
Prescription/Non prescription | Non prescription |
Manufacturer | Aprazer Healthcare Pvt. Ltd. |
Form | Tablet |
Shelf life | 24 month |
Sofokast plus tablets, which contain 400 mg Sofosbuvir is a nucleotide polymerase inhibitor, and includes antiviral drugs direct action. sofosbuvir is exposed to have a high barrier to growth resistance and inhibits the Cb NS5B Hep protein. Thus, Sofosbuvir interferes with the enzyme RNA polymerase by a cell worker who can perform the reproduction process. Consequently, Sofosbuvir stops hepatitis C virus replication and reduces the amount of Hep C virus in the liver. Sofosbuvir also acts to reduce liver damage and improve liver function.
Sofokast plus tablets also contains daclatasvir, a direct-acting antiviral drug that is indicated for a patient affected by hepatitis C virus infection. It will target the Hep C virus and stops numerous steps in the HCV reproduction process by preventing viral particles from making copies themselves, and helps the body remove the virus from the blood.
Absorption: –Peak plasma concentration is 0. 5-2 h after dose for 40% Sofosbuvir and in metabolite GS-331007 peak plasma concentration obtained 2-4 hours after administration where, as in Daclatasvir, peak plasma plasma concentration is within 2 hours after dose administration and bioavailability is 67%
Food effect:Sofosbuvir 400 mg and metabolite do not affect fatty flour. Hence, Sofosbuvir is managed without food. In Daclatasvir, 60 mg of the drug was not taken with or without food.
Distribution:Sofosbuvir 400 mg is about 51-65% bound to human plasma proteins, and the metabolite GS-331007 has minimal binding to human plasma proteins. And in Daclatasvir 60 mg protein binding protein is 99%
Metabolism:In the liver, Sofosbuvir 400 mg is extensively metabolized (4% and> 90%) to be converted into the pharmacologically active nucleoside analog of GS – 461203 triphosphate. Daclatasvir 60 mg metabolism based on CYP3A substrate with initial CYP isoform.
Elimination:The average total recovery dose of 400 mg Sofosbuvir was> 92% and included removal of 80%, 14% and 2, 5% in urine, feces, exhaled air. After a single dose Daclatasvir 60 mg radioactivity recovered to 88% via the faeces and 6, 6% through urine
Half the life of Sofosbuvir 400 mg and GS-331007 was 0, 4 and 27 hours, and Daclatasvir 60 mg had a half-life of 12 to 15 hours
Sofokast plus tablets also contains daclatasvir, a direct-acting antiviral drug that is indicated for a patient affected by hepatitis C virus infection. It will target the Hep C virus and stops numerous steps in the HCV reproduction process by preventing viral particles from making copies themselves, and helps the body remove the virus from the blood.
Absorption: –Peak plasma concentration is 0. 5-2 h after dose for 40% Sofosbuvir and in metabolite GS-331007 peak plasma concentration obtained 2-4 hours after administration where, as in Daclatasvir, peak plasma plasma concentration is within 2 hours after dose administration and bioavailability is 67%
Food effect:Sofosbuvir 400 mg and metabolite do not affect fatty flour. Hence, Sofosbuvir is managed without food. In Daclatasvir, 60 mg of the drug was not taken with or without food.
Distribution:Sofosbuvir 400 mg is about 51-65% bound to human plasma proteins, and the metabolite GS-331007 has minimal binding to human plasma proteins. And in Daclatasvir 60 mg protein binding protein is 99%
Explore More Products
© Affix Impex. All Rights Reserved (Terms of Use)
Developed and Managed by IndiaMART InterMESH Limited